Hospira buprenorphine and labetalol injections (Carpuject units), used in veterinary clinics
Recall announced May 22, 2024 by Hospira Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Potential packaging defect. It affects dogs, cats, rabbits and small pets and farm animals. The agency has not closed this recall.
- Brands
- Hospira
- Where sold
- Distributed nationwide to wholesalers and hospitals from September 2023 through April 2024.
- Last updated
- November 20, 2026
Products included
- Labetalol Hydrochloride Injection, USP, Carpuject cartridge (NDC 0409-2339-34 bundle; 0409-2339-24 carton), 20 mg/4 mL (5 mg/mL) (HJ7566; Best by 2025/05)
- Buprenorphine Hydrochloride Injection CIII, Carpuject cartridge (NDC 0409-2012-32 carton; 0409-2012-03 cartridge), 0.3 mg/mL, 10 cartridges per carton (HJ8546; Best by 2024/10)
- Buprenorphine Hydrochloride Injection CIII, Carpuject cartridge (NDC 0409-2012-32 carton; 0409-2012-03 cartridge), 0.3 mg/mL, 10 cartridges per carton (HJ3965; Best by 2024/09)
- Labetalol Hydrochloride Injection, USP, Carpuject cartridge (NDC 0409-2339-34 bundle; 0409-2339-24 carton), 20 mg/4 mL (5 mg/mL) (HN8747, HN8749; Best by 2025/09)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
